Literature DB >> 11557665

Adenovirus-mediated overexpression of dominant-negative mutant of c-Jun prevents intercellular adhesion molecule-1 induction by LDL: a critical role for activator protein-1 in endothelial activation.

N Wang1, L Verna, A Ballard, Y Zhu, M B Stemerman.   

Abstract

Low density lipoprotein (LDL) induces intercellular adhesion molecule-1 (ICAM-1) gene expression and leads to endothelial cell (EC) leukocyte adhesion. However, the transcriptional mechanism for LDL-induced EC perturbation remains to be fully explained. Activator protein-1 (AP-1) is induced after the exposure of ECs to LDL. In the present study, a regulated adenovirus expressing a dominant-negative mutant of c-Jun (TAM-67) was used to examine the role of AP-1 in the LDL-induced ICAM-1 activation. Overexpression of TAM-67 specifically inhibited AP-1 activation and prevented the LDL-activated surface expression of ICAM-1 protein in human umbilical vein ECs and human coronary artery ECs. Northern analyses and promoter transactivation assays indicated that this effect of TAM-67 was likely mediated through a suppression of the transcriptional regulation of the ICAM-1 gene. Functionally, TAM-67 attenuated leukocyte adherence to ECs in response to LDL. Furthermore, electrophoresis mobility shift assays and site-directed mutagenesis suggested that an AP-1-like motif in the promoter region of the human ICAM-1 gene was a critical cis element for LDL induction. These results, for the first time, provide evidence suggesting that AP-1 is a major regulatory mechanism leading to endothelial activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557665     DOI: 10.1161/hq0901.095549

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

1.  Translational control of JunB, an AP-1 transcription factor, in activated human endothelial cells.

Authors:  Douglas I Schmid; Hansjörg Schwertz; Huimiao Jiang; Robert A Campbell; Andrew S Weyrich; Thomas M McIntyre; Guy A Zimmerman; Larry W Kraiss
Journal:  J Cell Biochem       Date:  2013-07       Impact factor: 4.429

2.  MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells.

Authors:  Xiaomei Qin; Xiaohong Wang; Ying Wang; Zhihui Tang; Qinghua Cui; Jianzhong Xi; Yi-Shuan J Li; Shu Chien; Nanping Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-27       Impact factor: 11.205

3.  Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs.

Authors:  Xuefen Xie; Hailing Liao; Huaixin Dang; Wei Pang; Youfei Guan; Xian Wang; John Y-J Shyy; Yi Zhu; Frances M Sladek
Journal:  Mol Endocrinol       Date:  2009-01-29

4.  Shear stress activation of nuclear receptor PXR in endothelial detoxification.

Authors:  Xiaohong Wang; Xi Fang; Jing Zhou; Zhen Chen; Beilei Zhao; Lei Xiao; Ao Liu; Yi-Shuan J Li; John Y-J Shyy; Youfei Guan; Shu Chien; Nanping Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

5.  Comparative study on circulating endothelial progenitor cells in systemic lupus erythematosus patients at active stage.

Authors:  Xiao Li Deng; Xiao Xia Li; Xiang Yuan Liu; Lin Sun; Rui Liu
Journal:  Rheumatol Int       Date:  2009-10-22       Impact factor: 2.631

6.  Suppression of 2,3-oxidosqualene cyclase by high fat diet contributes to liver X receptor-alpha-mediated improvement of hepatic lipid profile.

Authors:  Huaixin Dang; Yan Liu; Wei Pang; Chenghong Li; Nanping Wang; John Y-J Shyy; Yi Zhu
Journal:  J Biol Chem       Date:  2009-01-01       Impact factor: 5.157

7.  Peroxisome Proliferator-Activated Receptor γ Regulates the Expression of Lipid Phosphate Phosphohydrolase 1 in Human Vascular Endothelial Cells.

Authors:  Yazi Huang; Beilei Zhao; Yahan Liu; Nanping Wang
Journal:  PPAR Res       Date:  2014-05-12       Impact factor: 4.964

8.  AAV-Mediated Expression of AP-1-Neutralizing RNA Decoy Oligonucleotides Attenuates Transplant Vasculopathy in Mouse Aortic Allografts.

Authors:  Anca Remes; Maximilian Franz; Franziska Mohr; Antje Weber; Kleopatra Rapti; Andreas Jungmann; Matthias Karck; Markus Hecker; Klaus Kallenbach; Oliver J Müller; Rawa Arif; Andreas H Wagner
Journal:  Mol Ther Methods Clin Dev       Date:  2019-10-02       Impact factor: 6.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.